个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

Antifungal Spectrum, In Vivo Efficacy, and Structure-Activity Relationship of Ilicicolin H

  作者 SINGH SHEO B; LIU WEIGUO; LI XIAOHUA; CHEN TOM; SHAFIEE ALI; CARD DEBORAH; ABRUZZO GEORGE; FLATTERY AMY; GILL CHARLES; THOMPSON JOHN R; ROSENBACH MARK; DREIKORN SARAH; HORNAK VIKTOR; MEINZ MARIA; KURTZ MYRA; KELLY ROSEMARIE; ONISHI JANET C  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2012年3-10;  页码  814-817  
  关联知识点  
 

[摘要]Ilicicolin H is a polyketide-nonribosomal peptide synthase (NRPS)-natural product isolated from Gliocadium roseum, which exhibits potent and broad spectrum antifungal activity, with sub-mu g/mL MICs against Candida spp., Aspergillus fumigatus, and Cryptococcus spp. It showed a novel mode of action, potent inhibition (IC50 = 2-3 ng/mL) of the mitochondrial cytochrome bc1 reductase, and over 1000-fold selectivity relative to rat liver cytochrome bc1 reductase. Ilicicolin H exhibited in vivo efficacy in murine models of Candida albicans and Cryptococcus neoformans infections, but efficacy may have been limited by high plasma protein binding. Systematic structural modification of ilicicolin H was undertaken to understand the structural requirement for the antifungal activity. The details of the biological activity of ilicicolin H and structural modification of some of the key parts of the molecule and resulting activity of the derivatives are discussed. These data suggest that the beta-keto group is critical for the antifungal activity.

 
      被申请数(1)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内